However, macular edema associated with certain secondary causes of ERM, such as diabetic retinopathy, retinal vein occlusion, and uveitis, may respond to intravitreal administration of anti-VEGF (vascular endothelial growth factor) agents, steroids, or non-steroidal agents. This evidence concerns the gene VEGFA and retinal vein occlusion.